Invention Grant
- Patent Title: Nitrogen-containing heterocyclic compound or salt thereof
- Patent Title (中): 含氮杂环化合物或其盐
-
Application No.: US14516337Application Date: 2014-10-16
-
Publication No.: US09145415B2Publication Date: 2015-09-29
- Inventor: Masaru Takasaki , Toshiaki Tsujino , Shintarou Tanabe , Megumi Ookubo , Kimihiko Sato , Atsush Hirai , Daisuke Terada , Shinsuke Inuki , Shinsuke Mizumoto
- Applicant: FUJIFILM Corporation
- Applicant Address: JP Tokyo
- Assignee: FUJIFILM Corporation
- Current Assignee: FUJIFILM Corporation
- Current Assignee Address: JP Tokyo
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2012-094184 20120417; JP2013-082479 20130315
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D471/04 ; C07D403/12 ; C07D401/14 ; C07D213/74 ; C07D401/12 ; C07D405/12 ; C07D239/48 ; C07D239/49 ; C07D409/12 ; C07D401/06 ; C07D403/04 ; C07D403/14 ; C07D413/04 ; C07D413/12 ; C07D413/14 ; C07D417/12 ; A61K31/44
Abstract:
The object is to provide an Fms-like tyrosine kinase 3 (FLT3) inhibitor useful as a therapeutic agent for acute myeloid leukemia (AML). A novel nitrogen-containing heterocyclic compound represented by the general formula [1] or a salt thereof is provided. The compound or a salt thereof of the present invention can be used as an active ingredient of a pharmaceutical composition for a treatment of a disease or condition relating to FLT3, such as acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL).
Public/Granted literature
- US20150045339A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR SALT THEREOF Public/Granted day:2015-02-12
Information query
